Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1981-07-16
1983-10-04
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
424310, 424361, 536 46, 536103, A61K 3173, C08B 3716
Patent
active
044077955
ABSTRACT:
An inclusion compound of p-hexadecylamino benzoic acid sodium salt in .beta.-cyclodextrin which provides enhanced bioavailability of this antiatherosclerotic agent.
REFERENCES:
patent: 3453257 (1969-07-01), Paramerter et al.
patent: 3453260 (1969-07-01), Paramerter et al.
patent: 3459732 (1969-08-01), Hull et al.
patent: 3472835 (1969-10-01), Buckler et al.
patent: 4066829 (1978-01-01), Nair et al.
patent: 4100342 (1978-07-01), Finley
patent: 4311694 (1982-01-01), Krueger et al.
Albright, et al., "Jour. of Pharmaceutical Science," vol. 68, No. 7, Jul. 1979, pp. 936-937.
Nicolau Gabriela
Tonelli Alfred P.
American Cyanamid Company
Brown Johnnie R.
Richards Jack W.
LandOfFree
Inclusion compound of p-hexadecylamino benzoic acid in cyclodext does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inclusion compound of p-hexadecylamino benzoic acid in cyclodext, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inclusion compound of p-hexadecylamino benzoic acid in cyclodext will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-972999